‘Delay in WHO Nod for Covaxin Suggests Problems Exist’
‘Delay in WHO Nod for Covaxin Suggests Problems Exist’
Oct 3, 2021
thewire.in
What is Covaxin, the COVID vaccine not approved in the US?
1:35
What is Covaxin, the COVID vaccine not approved in the US?
Dec 31, 2021
newsnationnow.com
Covaxin Vaccine FAQ: All That You Need To Know About This Vaccine
Covaxin Vaccine FAQ: All That You Need To Know About This Vaccine
May 4, 2021
onlymyhealth.com
'Delay in WHO Nod for Covaxin Suggests Problems Exist; This Is Serious Setback to Indian Science' In a 27-minute interview with Karan Thapar for The Wire, Dr Sabyasachi Chatterjee agreed that another indication the World Health Organization has concerns about Covaxin’s Phase 3 data and is thus delaying granting Emergency Use Authorization emerges when you compare how Covaxin has been treated with Pfizer, Moderna and AstraZeneca. Six weeks after Pfizer published its Phase 3 results the WHO grante
28:11
'Delay in WHO Nod for Covaxin Suggests Problems Exist; This Is Serious Setback to Indian Science' In a 27-minute interview with Karan Thapar for The Wire, Dr Sabyasachi Chatterjee agreed that another indication the World Health Organization has concerns about Covaxin’s Phase 3 data and is thus delaying granting Emergency Use Authorization emerges when you compare how Covaxin has been treated with Pfizer, Moderna and AstraZeneca. Six weeks after Pfizer published its Phase 3 results the WHO grante
4.6K viewsOct 2, 2021
FacebookTheWire.in
Covaxin, the homegrown coronavirus vaccine that was authorised for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its Phase 2 results. Medical journal Lancet has said that efficacy cannot be determined by Phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is "safe/immunogenic". The Lancet report says the results reported in the study of Phase 2 results do not permit efficacy assess
20:10
Covaxin, the homegrown coronavirus vaccine that was authorised for use in January before full clinical trial data, has been declared "safe, immunogenic with no serious side effects" by Lancet that has published its Phase 2 results. Medical journal Lancet has said that efficacy cannot be determined by Phase 2 trials but the vaccine made by Hyderabad-based Bharat Biotech is "safe/immunogenic". The Lancet report says the results reported in the study of Phase 2 results do not permit efficacy assess
27.9K viewsMar 9, 2021
FacebookNDTV
#Gravitas | #Covaxin has been denied emergency use authorisation in the US. The vaccine is yet to be listed on the WHO's list of approved vaccines. The lack of global approvals has put a question mark on travel, work & study plans of millions of Indians. Palki S Upadhyay tells you why | WION
4:09
#Gravitas | #Covaxin has been denied emergency use authorisation in the US. The vaccine is yet to be listed on the WHO's list of approved vaccines. The lack of global approvals has put a question mark on travel, work & study plans of millions of Indians. Palki S Upadhyay tells you why | WION
77.8K viewsJun 11, 2021
FacebookWION
Bharat Biotech's partner seeks Covaxin approval in US for children
Bharat Biotech's partner seeks Covaxin approval in US for children
Nov 6, 2021
INDIA TV
9:57
#DNA: Why is WHO delaying approval for Covaxin? Find out by watching this report #Covaxin #Covid19 | Zee News English
23.1K viewsOct 29, 2021
FacebookZee News English
20:49
Covaxin Supply Deficit: What was expected & what is the current situation? | The Big Story
Jun 30, 2021
timesnownews.com
Bharat Biotech’s Covaxin safe for children, well-tolerated in 2-18 years age-group: Lancet study
Jun 17, 2022
oneindia.com
3:17
Over 30% of Covaxin takers experienced nervous system disorders, menstrual abnormalities, suggests study Himani Chandna shares more details #Covaxin #Coronavirus #Vaccine #CoronaVaccine | News18
295 viewsMay 17, 2024
FacebookNews18
0:25
#Covaxin shows vaccine efficacy of 81% in phase 3 trial. What does the vaccine efficacy number mean? Here's everything you need to know! | News18
1.1K viewsMar 4, 2021
FacebookNews18
54:44
Did Bharat Biotech's response on Covaxin controversy settle the wrangle? | The Urban Debate
Jan 4, 2021
timesnownews.com
8:13
Covaxin and Covishield have been cleared for market approval by an expert panel of India's central drug authority in a significant move that will ensure easy availability of the vaccines. | NDTV
45.1K viewsJan 19, 2022
FacebookNDTV
'Coincidence that PM Modi received Covaxin': Owaisi raises questions over Covishield's efficacy
Mar 1, 2021
INDIA TV
2:56
Review Of Covaxin Shot Underway, May Get Recommendation In 24 Hours: WHO Official |
Oct 26, 2021
NDTV
3:10
Covaxin good & bad news: US agency acclaim; Brazil deal suspension for probe
Jun 30, 2021
Hindustan TimesAniruddh Misra
Bharat Biotech's Covaxin effective against new COVID-19 variants, reveals study
May 16, 2021
india.com
Submit Covaxin safety reports every 15 days, include mild side-effects — govt to Bharat Biotech
Jan 3, 2021
theprint.in
45:39
Covaxin gets emergency use nod for children aged 2-18 years; Crackdown on terror: NIA raids 16 places in J more
Oct 12, 2021
India TodayIndia Today Television
Covaxin controversy: Bypassing phases jeopardises system, say experts
Jan 4, 2021
India TodayPankaj Upadhyay
Covid-19 Vaccine Covishield, Covaxin से जुड़ी ये भयानक गलती न करें, वरना कोई फायदा नहीं
154.6K viewsMay 19, 2021
YouTubeThe Lallantop
3:41
'Covaxin phase 1 trial results are positive' says Sanjay Rai of AIIMS | EXCLUSIVE
274 viewsDec 17, 2020
YouTubeMIRROR NOW
12:04
Latest research on vaccine side effects, immune reaction and thrombosis risks | COVID-19 Special
2.9M viewsApr 15, 2021
YouTubeDW News
2:13
Explained: Why do some people get side effects after taking Covid-19 vaccines?
23.9K viewsJul 14, 2021
YouTubeThe Indian Express
7:26
Does Covaxin have calf serum? Here's what Congress said
14 viewsJun 17, 2021
DailymotionAaj Tak
19:45
The Development of Covaxin
790 viewsJan 5, 2021
YouTubeLabroots
5:12
Multiple Questions Arise Over Covaxin Approval
434 viewsJan 5, 2021
YouTubeNDTV
17:02
What Does Brazil’s Report on Covaxin’s Safety Mean for India?
5 views2 weeks ago
YouTubeThe Quint
5:57
Bharat Biotech's Covaxin Shows 78% Efficacy, Claims ICMR Study | Breaking News | India Today
18.4K viewsApr 21, 2021
YouTubeIndia Today
See more
Static thumbnail place holder